NDC 0409-1144-62 - Verapamil Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1144
- Requested NDC
- 0409-1144-62
- Package NDCs from labels
- 0409-1144-62, 0409-1144-02, 0409-1144-65, 0409-1144-05, 0409-1144-11, 0409-1144-10
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Verapamil Hydrochloride Injection, USP | Hospira, Inc. | 2026-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride Injection, USP | Hospira, Inc. | Pfizer Healthcare India Private Limited | Nitto Avecia Pharma Services, Inc. | 2026-04-29 | HUMAN PRESCRIPTION DRUG LABEL |
| VERAPAMIL HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-19 | HUMAN PRESCRIPTION DRUG LABEL |
| VERAPAMIL HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2019-12-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride - Cardinal Health | Cardinal Health | 2019-09-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1144-02 | Verapamil Hydrochloride | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 24 | |
| 0409-1144-05 | Verapamil Hydrochloride | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 24 | |
| 0409-1144-62 | Verapamil Hydrochloride | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 24 | |
| 0409-1144-65 | Verapamil Hydrochloride | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 24 | |
| 0409-1144-10 | Verapamil Hydrochloride | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 14 | |
| 0409-1144-11 | Verapamil Hydrochloride | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0409-1144 | VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 22 | Current NDC, Legacy NDC, 4 package rows | 20241109_1c993365-1b62-4524-e781-d307f28f63bc.zip |
| 0409-1144 | VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20241024_70057a53-ca29-4848-ab3d-5e691e2a14a3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-1144-01 | ML - Milliliter | 0409-1144 | 1c0cbad9-d3a6-4e81-a12d-bc7278813752 | 1 | 2012-07-24 |
| 0409-1144-02 | ML - Milliliter | 0409-1144 | 2a1dfbca-a12c-41cc-af25-c1d6dd5ebcd6 | 1 | 2012-07-24 |
| 0409-1144-05 | ML - Milliliter | 0409-1144 | 067508cf-4ac4-4905-9b50-eac564de3b98 | 1 | 2012-07-24 |
| 0409-1144-10 | ML - Milliliter | 0409-1144 | 69396de1-9dc4-4aa6-9115-796721a02be3 | 1 | 2018-07-03 |
| 0409-1144-11 | ML - Milliliter | 0409-1144 | 0547e790-5b24-4ff0-9cfd-aa764e9c15c1 | 1 | 2018-07-03 |
| 0409-1144-62 | ML - Milliliter | 0409-1144 | 499e8c34-0c1b-4fb9-9ebc-bf0c7900ee9d | 1 | 2019-07-02 |
| 0409-1144-65 | ML - Milliliter | 0409-1144 | 04b1829a-5f8e-4594-afae-8a316138740a | 1 | 2019-07-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | Cardinal Health 107, LLC | 48d75a7c-8329-48a8-bea0-a8c144ddf637 | 2026-08-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Metabatone | ARALIA RACEMOSA, AVENA SATIVA, BERBERIS VULGARIS, CAPSICUM ANNUUM, GINKGO BILOBA, PHYTOLACCA DECANDRA, HYPOTHALAMUS SUIS, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, FEL TAURI, HYALURONIDASE, PANCREAS SUIS, PANCREATINUM, PAPAIN, STOMACH (SUIS), L-ALANINE, L- ARGININE, L-CARNITINE, CYSTEINUM, L-GLUTAMINE, L-HISTIDINE, L-ISOLEUCINE, L-LEUCINE, L-LYSINE, L-METHIONINE, L-ORNITHINE, L-PROLINE, L-SERINE, L-TRYPTOPHAN, L-TYROSINE, L-VALINE, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, IODIUM, | Energique, Inc. | 9510bb76-b717-407d-b9e8-da7743e4cfc8 | 2026-07-31 | Warnings | 451W47IQ8X |
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 167c7a9c-1228-4fb2-a89c-d3e148386323 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | df79ee3a-f0ed-1cc7-e053-2995a90af97f | 2026-07-23 | Warnings, Adverse reactions | 1665057 V3888OEY5R |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |
| Saline | NASAL | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 71485e82-bf54-4b8b-8dd2-2a0761534520 | 2026-07-17 | Warnings | 451W47IQ8X |
| WHWSWB 0.9% SALINE | SODIUM CHLORIDE | Yiwu Huanshu E-commerce Co., Ltd | 5082b773-79b2-2501-e063-6394a90a170f | 2026-07-11 | Warnings | 451W47IQ8X |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | Lifestar Pharma LLC | df77b8d1-1d2b-4fea-a1e9-153bd25008a6 | 2026-07-10 | Warnings, Adverse reactions | 1665061 1665057 V3888OEY5R |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Hospira, Inc. | 1c993365-1b62-4524-e781-d307f28f63bc | 2026-07-09 | Warnings, Adverse reactions | ANDA070738 ANDA070737 0409-1144-65 0409-1144-02 0409-1144-05 0409-1144-62 0409-4011-01 0409-4011-61 0409-1144 0409-4011 00409114462 1665061 1665057 96edb388-f2c7-47cb-8cba-f4d9369b3dd1 1c993365-1b62-4524-e781-d307f28f63bc V3888OEY5R |
| SALINE NASAL | SODIUM CHLORIDE | ALAINA HEALTHCARE PRIVATE LIMITED | ed30a7f9-7132-42da-9bed-63a9b1c80ab2 | 2026-07-07 | Warnings | 451W47IQ8X |
| Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) | NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) | Reedfresh Co., LTD | 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 | 2026-07-05 | Warnings | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Protective Industrial Products, Inc. | 558e5926-9027-d3f6-e063-6294a90ab121 | 2026-07-02 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.